Global cancer burden growing, amidst mounting need for services.
出版信息
Saudi Med J. 2024 Mar;45(3):326-327.
Abstract
摘要
相似文献
1
Global cancer burden growing, amidst mounting need for services.全球癌症负担不断增加，对服务的需求也日益迫切。
Saudi Med J. 2024 Mar;45(3):326-327.
2
Managing the changing burden of cancer in Asia.管理亚洲不断变化的癌症负担。
BMC Med. 2014 Jan 8;12:3. doi: 10.1186/1741-7015-12-3.
3
Mounting cancer burden tests Africa's health resources.日益加重的癌症负担考验着非洲的卫生资源。
Lancet. 2015 Jun 27;385(9987):2564-5. doi: 10.1016/S0140-6736(15)61148-5.
4
The global burden of cancer.全球癌症负担。
Best Pract Res Clin Anaesthesiol. 2013 Dec;27(4):399-408. doi: 10.1016/j.bpa.2013.10.010. Epub 2013 Oct 24.
5
Aligning Cancer Clinical Trials With Cancer Burden: Need for Greater Global Leadership, Resources, and Vision.使癌症临床试验与癌症负担相匹配：需要更强的全球领导力、资源和愿景。
JAMA Oncol. 2021 Mar 1;7(3):357-358. doi: 10.1001/jamaoncol.2020.7293.
6
Climate change and cancer.气候变化与癌症。
CA Cancer J Clin. 2020 Jul;70(4):239-244. doi: 10.3322/caac.21610. Epub 2020 May 18.
7
Incidence, prevalence, mortality, disability-adjusted life years and risk factors of cancer in Australia and comparison with OECD countries, 1990-2015: findings from the Global Burden of Disease Study 2015.1990 - 2015年澳大利亚癌症的发病率、患病率、死亡率、伤残调整生命年及风险因素，并与经合组织国家比较：全球疾病负担研究2015的结果
Cancer Epidemiol. 2018 Feb;52:43-54. doi: 10.1016/j.canep.2017.11.007. Epub 2017 Dec 5.
8
Cancer control-planning and monitoring population-based systems.癌症控制——基于人群的规划与监测系统
Tumori. 2009 Sep-Oct;95(5):568-78. doi: 10.1177/030089160909500501.
9
Disparities in cancer care between the United States of America and India and opportunities for surgeons to lead.美国和印度之间癌症护理的差距及外科医生发挥领导作用的机会。
J Surg Oncol. 2010 Jul 1;102(1):100-5. doi: 10.1002/jso.21579.
10
The Growing Burden of Cancer in Adolescent and Young Adults in Asia: A Call to Action.亚洲青少年和青年成年人中不断增加的癌症负担：行动呼吁。
J Adolesc Young Adult Oncol. 2024 Feb;13(1):1-7. doi: 10.1089/jayao.2023.0008. Epub 2023 Jun 15.
引用本文的文献
1
Psychometric properties of patient-reported outcome measures for symptom assessment in patients with cancer receiving immunotherapy: A systematic review following the COSMIN 2.0 guidelines.癌症免疫治疗患者症状评估中患者报告结局指标的心理测量学特性：遵循COSMIN 2.0指南的系统评价
Asia Pac J Oncol Nurs. 2025 Aug 19;12:100774. doi: 10.1016/j.apjon.2025.100774. eCollection 2025 Dec.
2
Efficacy and safety of utidelone in pretreated patients with metastatic breast cancer in China: a multicenter, real-world study.在中国接受过治疗的转移性乳腺癌患者中优替德隆的疗效和安全性：一项多中心真实世界研究
Ther Adv Med Oncol. 2025 Aug 30;17:17588359251368684. doi: 10.1177/17588359251368684. eCollection 2025.
3
A novel chromen-based small molecule induces apoptosis and modulates cellular response to triple-negative breast cancer.一种新型的基于色烯的小分子可诱导细胞凋亡并调节对三阴性乳腺癌的细胞反应。
Sci Rep. 2025 Aug 29;15(1):31914. doi: 10.1038/s41598-025-16195-y.
4
SERS- and SEIRA-Based Characterization and Sensing of Highly Selective Bradykinin B2 Receptor Antagonists.基于表面增强拉曼光谱（SERS）和表面增强红外吸收光谱（SEIRA）的高选择性缓激肽B2受体拮抗剂的表征与传感
Int J Mol Sci. 2025 Aug 21;26(16):8089. doi: 10.3390/ijms26168089.
5
Mechanism of RCD and the Role of Different Death Signaling Pathways in Cancer.细胞程序性死亡机制以及不同死亡信号通路在癌症中的作用
Biomedicines. 2025 Aug 2;13(8):1880. doi: 10.3390/biomedicines13081880.
6
Analysis of novel therapeutic targets and construction of a prognostic model for hepatocellular carcinoma.肝细胞癌新治疗靶点分析及预后模型构建
PeerJ. 2025 Aug 22;13:e19899. doi: 10.7717/peerj.19899. eCollection 2025.
7
Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities.个性化治疗中的癌症干细胞：机制、微环境相互作用及治疗弱点
Front Cell Dev Biol. 2025 Jul 30;13:1619597. doi: 10.3389/fcell.2025.1619597. eCollection 2025.
8
A retrospective assessment of the implementation of virtual medical physics educational initiatives using the consolidated framework for implementation research.使用实施研究综合框架对虚拟医学物理教育倡议的实施情况进行回顾性评估。
Front Med (Lausanne). 2025 Jul 29;12:1625455. doi: 10.3389/fmed.2025.1625455. eCollection 2025.
9
Effect of virtual reality on pain in oncology patients: A systematic review.虚拟现实对肿瘤患者疼痛的影响：一项系统综述。
Medicine (Baltimore). 2025 Aug 8;104(32):e43487. doi: 10.1097/MD.0000000000043487.
10
Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages.华蟾毒精通过调节肿瘤相关巨噬细胞中的糖代谢重编程抑制非小细胞肺癌的侵袭和迁移。
Drug Des Devel Ther. 2025 Aug 2;19:6647-6664. doi: 10.2147/DDDT.S531190. eCollection 2025.
Zotero 插件